Celera's Q4 Sales Fall 11 Percent on Lower Licensing Revenues

The firm, which announced separately today that it being acquired by Quest Diagnostics, had lower revenues for the quarter and year.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories